Conversely, tumour‐suppressor functions of HOXB13 in prostate cancer seem to depend on its ability to block cell division through the downregulation of cyclin D1 through competition for TCF4 binding to its promoter,87, 88 and androgen signalling through direct interaction with the androgen receptor.89, 122. Here, HOXB13 is linked to neoplasm.